|
시장보고서
상품코드
1991384
엑소좀 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)Global Exosomes Market Size, Share, Trends & Growth Analysis Report 2026-2034 |
||||||
엑소좀 시장 규모는 2025년 5억 9,000만 달러에서 2034년에는 63억 8,000만 달러에 달할 것으로 예상되고, 2026년부터 2034년까지 CAGR 30.37%로 성장할 것으로 전망됩니다.
세계 엑소좀 시장은 세포생물학 및 재생의료 분야의 연구 발전으로 인해 괄목할 만한 성장을 거듭하고 있습니다. 엑소좀은 세포에서 방출되는 미세한 세포외 소포이며, 세포 간 소통과 분자 수송에 중요한 역할을 합니다. 과학자들은 특히 종양학 및 재생의학 분야에서 진단, 약물전달, 치료에의 적용 가능성을 모색하고 있습니다.
엑소좀 시장 확대를 뒷받침하는 몇 가지 요인이 있습니다. 생물 의학 연구에 대한 투자 증가와 맞춤형 의료에 대한 관심이 높아짐에 따라 과학자들은 엑소좀의 치료 가능성을 조사하고 있습니다. 단백질이나 RNA와 같은 생체분자를 운반할 수 있는 능력을 가진 엑소좀은 질병 탐지 및 표적치료에 있어 유용한 도구가 되고 있습니다.
향후 연구의 발전과 임상 응용의 발전에 따라 엑소좀 시장은 확대될 것으로 예상됩니다. 분리 및 특성화 기술의 향상으로 의학 연구 및 치료법 개발에서 엑소좀의 활용을 촉진할 수 있습니다. 생명공학 및 생명과학 산업이 혁신을 거듭하는 가운데, 엑소좀은 차세대 치료 전략의 중요한 구성요소가 될 것입니다.
목차
제1장 소개
제2장 주요 요약
제3장 시장 변수, 동향, 프레임워크
제4장 세계의 엑소좀 시장 : 제품 및 서비스별
제5장 세계의 엑소좀 시장 : 용도별
제6장 세계의 엑소좀 시장 : 적응증별
제7장 세계의 엑소좀 시장 : 최종사용자별
제8장 세계의 엑소좀 시장 : 지역별
제9장 경쟁 구도
제10장 기업 개요
KSM 26.04.27The Exosomes Market size is expected to reach USD 6.38 Billion in 2034 from USD 0.59 Billion (2025) growing at a CAGR of 30.37% during 2026-2034.
The global exosomes market has experienced significant growth due to increasing research in cell biology and regenerative medicine. Exosomes are tiny extracellular vesicles released by cells that play an important role in cell communication and molecular transport. Scientists are exploring their potential applications in diagnostics, drug delivery, and therapeutic treatments, particularly in oncology and regenerative medicine.
Several drivers are supporting the expansion of the exosomes market. Growing investment in biomedical research and increasing interest in personalized medicine have encouraged scientists to study the therapeutic potential of exosomes. Their ability to carry biological molecules such as proteins and RNA makes them valuable tools in disease detection and targeted therapies.
Looking ahead, the exosomes market is expected to expand as research advances and clinical applications develop. Improvements in isolation and characterization technologies may enhance the use of exosomes in medical research and treatment development. As biotechnology and life sciences industries continue to innovate, exosomes are likely to become an important component of next-generation therapeutic strategies.
MARKET SEGMENTATION
By Products & Services
- Kits & Reagents
- Antibodies
- Isolation, Purification, Quantitation Kits & Reagents
- Other Kits & Reagents
- Instruments
- Services
By Application
- Diagnostic
- Therapeutic
By Indication
- Cancer
- Neurodegenerative Diseases
- Cardiovascular Diseases
- Infectious Diseases
- Other Indications
By End-Users
- Pharmaceutical & Biotechnology Companies
- Hospitals & Diagnostics Centers
- Academic & Research Institutes
COMPANIES PROFILED
- Thermo Fisher Scientific Inc, BioTechne Corp, QIAGEN, Beckam Coulter Danaher Corp, Diagenode Hologic Inc, Lonza, Abcam, RoosterBio Inc, Miltenyi Biotech, Fujifilm Holdings Corp, Hitachi Chemical Diagnostics Inc, Clara Biotech
- We can customise the report as per your requirements.
TABLE OF CONTENTS
Chapter 1. PREFACE
- 1.1. Market Segmentation & Scope
- 1.2. Market Definition
- 1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
- 1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources
Chapter 2. EXECUTIVE SUMMARY
- 2.1. Market Snapshot
- 2.2. Segmental Outlook
- 2.3. Competitive Outlook
Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK
- 3.1. Market Lineage Outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Value Chain Analysis
- 3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
- 3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
- 3.6. Porter's Five Forces Analysis
- 3.7. PESTLE Analysis
Chapter 4. GLOBAL EXOSOMES MARKET: BY PRODUCTS & SERVICES 2022-2034 (USD MN)
- 4.1. Market Analysis, Insights and Forecast Products & Services
- 4.2. Kits & Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.3. Antibodies Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.4. Isolation, Purification, Quantitation Kits & Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.5. Other Kits & Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.6. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.7. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 5. GLOBAL EXOSOMES MARKET: BY APPLICATION 2022-2034 (USD MN)
- 5.1. Market Analysis, Insights and Forecast Application
- 5.2. Diagnostic Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.3. Therapeutic Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 6. GLOBAL EXOSOMES MARKET: BY INDICATION 2022-2034 (USD MN)
- 6.1. Market Analysis, Insights and Forecast Indication
- 6.2. Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.3. Neurodegenerative Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.4. Cardiovascular Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.5. Infectious Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.6. Other Indications Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 7. GLOBAL EXOSOMES MARKET: BY END-USERS 2022-2034 (USD MN)
- 7.1. Market Analysis, Insights and Forecast End-users
- 7.2. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 7.3. Hospitals & Diagnostics Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 7.4. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 8. GLOBAL EXOSOMES MARKET: BY REGION 2022-2034 (USD MN)
- 8.1. Regional Outlook
- 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.2.1 By Products & Services
- 8.2.2 By Application
- 8.2.3 By Indication
- 8.2.4 By End-users
- 8.2.5 United States
- 8.2.6 Canada
- 8.2.7 Mexico
- 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.3.1 By Products & Services
- 8.3.2 By Application
- 8.3.3 By Indication
- 8.3.4 By End-users
- 8.3.5 United Kingdom
- 8.3.6 France
- 8.3.7 Germany
- 8.3.8 Italy
- 8.3.9 Russia
- 8.3.10 Rest Of Europe
- 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.4.1 By Products & Services
- 8.4.2 By Application
- 8.4.3 By Indication
- 8.4.4 By End-users
- 8.4.5 India
- 8.4.6 Japan
- 8.4.7 South Korea
- 8.4.8 Australia
- 8.4.9 South East Asia
- 8.4.10 Rest Of Asia Pacific
- 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.5.1 By Products & Services
- 8.5.2 By Application
- 8.5.3 By Indication
- 8.5.4 By End-users
- 8.5.5 Brazil
- 8.5.6 Argentina
- 8.5.7 Peru
- 8.5.8 Chile
- 8.5.9 Rest of Latin America
- 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.6.1 By Products & Services
- 8.6.2 By Application
- 8.6.3 By Indication
- 8.6.4 By End-users
- 8.6.5 Saudi Arabia
- 8.6.6 UAE
- 8.6.7 Israel
- 8.6.8 South Africa
- 8.6.9 Rest of the Middle East And Africa
Chapter 9. COMPETITIVE LANDSCAPE
- 9.1. Recent Developments
- 9.2. Company Categorization
- 9.3. Supply Chain & Channel Partners (based on availability)
- 9.4. Market Share & Positioning Analysis (based on availability)
- 9.5. Vendor Landscape (based on availability)
- 9.6. Strategy Mapping
Chapter 10. COMPANY PROFILES OF GLOBAL EXOSOMES INDUSTRY
- 10.1. Top Companies Market Share Analysis
- 10.2. Company Profiles
- 10.2.1 Thermo Fisher Scientific Inc
- 10.2.2 Bio-Techne Corp
- 10.2.3 QIAGEN
- 10.2.4 Beckam Coulter (Danaher Corp)
- 10.2.5 Diagenode (Hologic Inc)
- 10.2.6 Lonza
- 10.2.7 Abcam
- 10.2.8 RoosterBio Inc
- 10.2.9 Miltenyi Biotech
- 10.2.10 Fujifilm Holdings Corp
- 10.2.11 Hitachi Chemical Diagnostics Inc
- 10.2.12 Clara Biotech
